Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the ...
FDA draft guidance backs alternatives to animal testing in early drug development, outlining validation for new approach ...
As regulatory authorities accelerate the use of New Approach Methodologies (NAMs), the drug discovery landscape is changing dramatically. This webinar explores how NAMs, immunology-driven platforms, ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced plans in 2025 to reduce animal testing requirements in biomedical research. New approach ...
In what the U.S. FDA has dubbed a milestone move toward fewer animal studies in drug development, the agency published a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results